|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Samsung Medical Center |
|---|---|
| Information provided by: | Samsung Medical Center |
| ClinicalTrials.gov Identifier: | NCT00624039 |
Purpose
The purpose of this study is to investigate the changes in the pilocarpine-induced ciliary body movement before and after cataract extraction in order to determine the effect of lens sclerosis on the ciliary muscle contractility.
| Condition | Intervention |
|---|---|
|
Presbyopia Cataract |
Other: UBM with pilocarpine in presbyopia |
| Study Type: | Interventional |
| Study Design: | Basic Science, Double Blind (Investigator, Outcomes Assessor), Uncontrolled, Single Group Assignment |
| Official Title: | The Effect of Cataract Extraction on the Contractility of Ciliary Muscle |
| Enrollment: | 15 |
| Study Start Date: | May 2006 |
| Estimated Study Completion Date: | March 2008 |
| Estimated Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1
ultrasound biomicrocopic examinations and pilocarpine instillation
|
Other: UBM with pilocarpine in presbyopia
ultrasound biomicroscopic examination in both eyes 30 minutes after one drop of 2% pilocarpine hydrochloride (Ocucarpine®, Samil Pharm., Seoul, Korea) instillation before and two months after cataract surgery
|
The functional changes in the ciliary body in presbyopia are not only important in a study of the mechanism for presbyopia but are also a key to various procedures or devices used to restore accommodation. Therefore, it is becoming increasingly important to quantify the in vivo accommodative changes in the aging ciliary muscle with and without a lens. We are going to evaluate the changes in the pilocarpine-induced contractility of the ciliary muscle in eyes with presbyopia before and after cataract extraction using ultrasound biomicroscopy (UBM).UBM will be performed with and without instilling 2 % pilocarpine, as well as before and 2 months after cataract extraction. Images of the ciliary body will be compared visually using Adobe Photoshop 7.0.
Eligibility| Ages Eligible for Study: | 55 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Korea, Republic of | |
| Samsung Medical Center | |
| Seoul, Korea, Republic of, 135-710 | |
| Study Director: | Changwon Kee, M.D. | Department of Ophthalmology, Samsung Medical Center, Ilwon-dong, Kangnam-gu, Seoul, 135-710, Republic of Korea. E-mail: ckee@skku.edu |
More Information
| Responsible Party: | Department of Ophthalmology, Samsung Medical Center, Seoul, Korea ( Changwon Kee ) |
| Study ID Numbers: | CB2006 |
| Study First Received: | February 18, 2008 |
| Last Updated: | February 18, 2008 |
| ClinicalTrials.gov Identifier: | NCT00624039 |
| Health Authority: | South Korea: Institutional Review Board |
|
presbyopia |
|
Eye Diseases Cataract Presbyopia |
Pilocarpine Lens Diseases Refractive Errors |
|
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Cholinergic Agonists Autonomic Agents Miotics |
Physiological Effects of Drugs Muscarinic Agonists Peripheral Nervous System Agents Cholinergic Agents Pharmacologic Actions |
